Specific to SAEs, agents such as alpha-2 agonists (cardiac arrest),35 gabapentinoids (respiratory depression),36 and NSAIDs/COX-2 inhibitors (bleeding and myocardial events)37 have adverse effects which could preclude their use. Here, PSMA2 is linked to respiratory depression.